Stevanato Group S.p.A. Ordinary Shares (NY:STVN)

Lost Money on Stevanato Group S.p.A. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 28.57% Share Price Drop

Today 12:20 EST

From Glancy Prongay Wolke & Rotter LLP

Did You Lose Money on Stevanato Group S.p.A. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 28.57% Share Price Decline

Performance

52-Week Range 50.2% below 52-week high

13.44

12.0552W Low 27.0052W High

1 Week 35.4% below 1-week high

12.051W Low 20.801W High

Stevanato Group S.p.A. Ordinary Shares (STVN) traded between $12.05 and $27.00 over the past 52 weeks and last traded at $13.44, 50.2% below its 52-week high. Over the past week it ranged between $12.05 and $20.80.

Past 12 Months

-33.6%

-33.0%

-33.1%

-29.3%

-34.7%

-45.7%

1W -$6.80

1M -$6.61

3M -$6.66

6M -$5.56

YTD -$7.14

1Y -$11.30

STVN was -45.7% over the past year, -29.3% over six months, -34.7% year to date, -33.6% in the last week.

12 Months vs Market

STVN

-45.7%

DIA

+13.2%

SPY

+13.6%

QQQ

+11.7%

IWM

+17.8%

Over the past 12 months STVN returned -45.7% versus DIA (Dow) +13.2%, SPY (S&P 500) +13.6%, QQQ (Nasdaq 100) +11.7% and IWM (Russell 2000) +17.8%.

Volume & Liquidity 8.57× 3-mo avg

Today 4,406,657 3-mo avg 513.9K

2.2M

768.5K

513.9K

445.2K

YTD

535.8K

501.3K

STVN most recently traded 4,406,657 shares against a 3-month average daily volume of 513.9K.

More News

Today 12:12 EST

From The Law Offices of Howard G. Smith

Stevanato Group (STVN) Shareholder Investigation Following Stock Decline – Kehoe Law Firm, P.C.

Today 8:38 EST

From Kehoe Law Firm

Via GlobeNewswire

Stevanato Group Q3 Earnings Call Highlights ↗

Today 4:14 EST

Via MarketBeat

Stevanato (STVN) Q3 2026 Earnings Call Transcript ↗

November 03, 2026

US Stock Gap Movers: Up and Down Names in Today's Session ↗

November 03, 2026

Via Chartmill

Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026

November 03, 2026

Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection

October 27, 2026

Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026

October 20, 2026

Stevanato Group to Participate in Two Upcoming Investor Conferences

September 08, 2026

Stevanato Group Q2 Earnings Call Highlights ↗

August 09, 2026

Via MarketBeat

Stevanato (STVN) Q2 2026 Earnings Call Transcript ↗

August 04, 2026

Stevanato Group Q2 2026 Earnings Call: Complete Transcript ↗

August 04, 2026

Via Benzinga

Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026

August 04, 2026

Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries

July 30, 2026

Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026

July 21, 2026

From Stevanato Group S.p.A

2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now ↗

June 09, 2026

Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management

June 08, 2026

From Stevanato Group

Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting

June 03, 2026

Stevanato (STVN) Q1 2026 Earnings Transcript ↗

May 08, 2026

Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026

May 07, 2026

Stevanato Group to Participate in Three Upcoming Investor Conferences

May 04, 2026

Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026

April 23, 2026

From Stevanato Group

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

March 12, 2026